Adalimumab and Infliximab ( DrugBank: Adalimumab, Infliximab )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
96	Crohn disease	2

96. Crohn disease

---

Clinical trials : 2,442 /  Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02332356 (ClinicalTrials.gov)	September 2014	4/1/2015	Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease	Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease	Crohn Disease	Drug: azathioprine or adalimumab and infliximab	Tokyo Medical and Dental University	NULL	Recruiting	16 Years	65 Years	All	100	Phase 3	Japan
2	NCT01338740 (ClinicalTrials.gov)	April 2011	18/4/2011	Switching From Adalimumab to Infliximab	Prospective Study to Assess the Efficacy of Switching to Infliximab in Moderately to Severely Active Chrohn's Disease Patients With Primary Non-response or Loss of Response to Adalimumab	Crohn's Disease	Drug: Adalimumab and Infliximab	University Hospital, Ghent	Abbott	Completed	18 Years	75 Years	All	21		Belgium